Molecular pathogenesis of human hepatocellular carcinoma

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Nature Genetics

• Publication date

  2002-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/ng0802-339PMID 12149612
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Low proliferative activity in macroregenerative nodules: evidence for an alternate hypothesis concerning human hepatocarcinogenesis.

  2008cited by this paper
• Molecular Genetic Alterations in Primary Hepatocellular Neoplasms

  2002cited by this paper
• Quantitative evaluation of genomic instability as a possible predictor for development of hepatocellular carcinoma : Comparison of loss of heterozygosity and replication error

  2002cited by this paper
• Hepatitis B, aflatoxin B(1), and p53 codon 249 mutation in hepatocellular carcinomas from Guangxi, People's Republic of China, and a meta-analysis of existing studies.

  2001cited by this paper
• Expression profiling suggested a regulatory role of liver-enriched transcription factors in human hepatocellular carcinoma.

  2001cited by this paper
• Genome-wide hypomethylation in hepatocellular carcinogenesis.

  2001cited by this paper
• Genome-wide analysis of gene expression in human hepatocellular carcinomas using cDNA microarray: identification of genes involved in viral carcinogenesis and tumor progression.

  2001cited by this paper
• Differential gene expression of hepatocellular carcinoma using cDNA microarray analysis.

  2001cited by this paper
• Somatic mutation of mitochondrial DNA in cancerous and noncancerous liver tissue in individuals with hepatocellular carcinoma.

  2001cited by this paper
• X protein of hepatitis B virus modulates cytokine and growth factor related signal transduction pathways during the course of viral infections and hepatocarcinogenesis.

  2001cited by this paper
• Expression of mRNA for DNA methyltransferases and methyl‐CpG–binding proteins and DNA methylation status on CpG islands and pericentromeric satellite regions during human hepatocarcinogenesis

  2001cited by this paper
• The chemistry and biology of aflatoxin B(1): from mutational spectrometry to carcinogenesis.

  2001cited by this paper
• Differentiation of liver cell adenomas from well‐differentiated hepatocellular carcinomas by comparative genomic hybridization

  2001cited by this paper
• An early lesion in hepatic carcinogenesis: Loss of heterozygosity in human cirrhotic livers and dysplastic nodules at the 1p36‐p34 region

  2001cited by this paper
• Serial analysis of gene expression in chronic hepatitis C and hepatocellular carcinoma.

  2001cited by this paper
• Comparative Genomic Hybridization of Hepatocellular Carcinoma: Correlation With Fluorescence In Situ Hybridization in Paraffin-embedded Tissue

  2001cited by this paper
• Human hepatocellular carcinoma is characterized by a highly consistent pattern of genomic imbalances, including frequent loss of 16q23.1–24.1

  2001cited by this paper
• Expression of mutant nuclear β‐catenin correlates with non‐invasive hepatocellular carcinoma, absence of portal vein spread, and good prognosis

  2001cited by this paper
• Clonal analysis of hepatocellular carcinoma and dysplastic nodule by methylation pattern of X-chromosome-linked human androgen receptor gene.

  2001cited by this paper
• Differential gene expression between chronic hepatitis B and C hepatic lesion.

  2001cited by this paper
• Application of cDNA microarray to the study of arsenic-induced liver diseases in the population of Guizhou, China.

  2001cited by this paper
• A mutator phenotype in cancer.

  2001cited by this paper
• Detection of hypermethylation of the p16INK4A gene promoter in chronic hepatitis and cirrhosis associated with hepatitis B or C virus

  2001cited by this paper
• Cancer burden in the year 2000. The global picture.

  2001cited by this paper
• Detection of hypermethylation of thep16INK4A gene promoter in chronic hepatitis and cirrhosis associated with hepatitis B or C virus

  2001cited by this paper
• Outcomes of dysplastic nodules in human cirrhotic liver: a clinicopathological study.

  2000cited by this paper
• Expression of telomerase-associated protein 1 and telomerase reverse transcriptase in hepatocellular carcinoma

  2000cited by this paper
• GSTP1 CpG island DNA hypermethylation in hepatocellular carcinomas.

  2000cited by this paper
• Searching for genetic determinants in the new millennium

  2000cited by this paper
• Aberrant DNA methylation precedes loss of heterozygosity on chromosome 16 in chronic hepatitis and liver cirrhosis.

  2000cited by this paper
• Distinct chromosomal abnormality pattern in primary liver cancer of non-B, non-C patients

  2000cited by this paper
• Increased p53 mutation load in nontumorous human liver of wilson disease and hemochromatosis: oxyradical overload diseases.

  2000cited by this paper
• Clonal Analysis of Micronodules in Virus C-Induced Liver Cirrhosis Using Laser Capture Microdissection (LCM) and HUMARA Assay

  2000cited by this paper
• Chromosomal changes and clonality relationship between primary and recurrent hepatocellular carcinoma.

  2000cited by this paper
• Frequent chromosomal instability but no microsatellite instability in hepatocellular carcinomas.

  2000cited by this paper
• Quantitative evaluation of genomic instability as a possible predictor for development of hepatocellular carcinoma: Comparison of loss of heterozygosity and replication error

  2000cited by this paper
• Genetic instability and aberrant DNA methylation in chronic hepatitis and cirrhosis—A comprehensive study of loss of heterozygosity and microsatellite instability at 39 loci and DNA hypermethylation on 8 CpG islands in microdissected specimens from patients with hepatocellular carcinoma

  2000cited by this paper
• Oral field cancerization: carcinogen-induced independent events or micrometastatic deposits?

  2000cited by this paper
• Genomic aberrations in human hepatocellular carcinomas of differing etiologies.

  2000cited by this paper
• Comprehensive allelotype study of hepatocellular carcinoma: Potential differences in pathways to hepatocellular carcinoma between hepatitis B virus–positive and –negative tumors

  2000cited by this paper
• Loss-of-heterozygosity analysis of small-cell lung carcinomas using single-nucleotide polymorphism arrays

  2000cited by this paper
• p16 is a major inactivation target in hepatocellular carcinoma

  2000cited by this paper
• Marked genetic similarities between hepatitis B virus‐positive and hepatitis C virus‐positive hepatocellular carcinomas

  2000cited by this paper
• Genetics of hepatocellular carcinoma.

  2000cited by this paper
• Clonal expansion in evolution of chronic hepatitis to hepatocellular carcinoma as seen at an X‐chromosome locus

  2000cited by this paper
• Differentiation of multicentric origin from intra‐organ metastatic spread of hepatocellular carcinomas by comparative genomic hybridization

  2000cited by this paper
• A comprehensive karyotypic study on human hepatocellular carcinoma by spectral karyotyping

  2000cited by this paper
• Fractional allelic loss in non–end‐stage cirrhosis: Correlations with hepatocellular carcinoma development during follow‐up

  2000cited by this paper
• AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1

  2000cited by this paper
• Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.

  2000cited by this paper
• Beta-catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis.

  2000cited by this paper
• Molecular changes in hepatocellular dysplastic nodules on microdissected liver biopsies

  2000cited by this paper
• DLC-1 is deleted in primary hepatocellular carcinoma and exerts inhibitory effects on the proliferation of hepatoma cell lines with deleted DLC-1.

  2000cited by this paper
• Gain of imprinting at chromosome 11p15: A pathogenetic mechanism identified in human hepatocarcinomas.

  2000cited by this paper
• Precancerous hepatic nodules had significant levels of telomerase activity determined by sensitive quantitation using a hybridization protection assay

  2000cited by this paper
• Microsatellite instability and mutations of E2F-4 in hepatocellular carcinoma from Korea.

  2000cited by this paper
• Transgenic mouse models in carcinogenesis research and testing.

  2000cited by this paper
• Alterations of P19ARF in rodent hepatoma cell lines but not in human primary liver cancer.

  2000cited by this paper
• Natural history of chronic hepatitis B virus infection in adults with emphasis on the occurrence of cirrhosis and hepatocellular carcinoma

  2000cited by this paper
• Telomerase and human tumorigenesis.

  2000cited by this paper
• Lack of frameshift mutations at coding mononucleotide repeats in hepatocellular carcinoma in Japanese patients

  2000cited by this paper
• Recurrent chromosome alterations in hepatocellular carcinoma detected by comparative genomic hybridization

  2000cited by this paper
• Recurrent chromosome alterations in hepatocellular carcinoma detected by comparative genomic hybridization

  2000cited by this paper
• p16INK4 gene mutation and allelic loss of chromosome 9p21-22 in Taiwanese hepatocellular carcinoma.

  2000cited by this paper
• Expression and localization of vascular endothelial growth factor receptors in human hepatocellular carcinoma and non-HCC tissues.

  2000cited by this paper
• Hypomethylation of LINE1 retrotransposon in human hepatocellular carcinomas, but not in surrounding liver cirrhosis.

  2000cited by this paper
• Tchou, J.C. et al. GSTP1 CpG island DNA hypermethylation in hepatocellular carcinoma. Int. J. Oncol. 16, 663−676

  2000cited by this paper
• Molecular cytogenetic evaluation of virus‐associated and non‐viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias

  2000cited by this paper
• Molecular profiling of human cancer

  2000cited by this paper
• Epidemiology of Primary Liver Cancer

  1999cited by this paper
• Mouse Liver Tumorigenesis: Models, Mechanisms, and Relevance to Human Disease

  1999cited by this paper
• Microsatellite instability and p53 mutations in hepatocellular carcinoma.

  1999cited by this paper
• Close correlation between β-catenin gene alterations and nuclear accumulation of the protein in human hepatocellular carcinomas

  1999cited by this paper
• DNA hypermethylation at the D17S5 locus and reduced HIC‐1mRNA expression are associated with hepatocarcinogenesis

  1999cited by this paper
• Frameshift mutation, microsatellites and mismatch repair.

  1999cited by this paper
• Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis

  1999cited by this paper
• A novel sperm-specific hypomethylation sequence is a demethylation hotspot in human hepatocellular carcinomas.

  1999cited by this paper
• Comparative hepatocellular cancer genetics.

  1999cited by this paper
• Telomerase activity in precancerous hepatic nodules

  1999cited by this paper
• Genome-wide analysis of DNA copy-number changes using cDNA microarrays

  1999cited by this paper
• Comparative hepatocellular cancer genetics.

  1999cited by this paper
• Telomerase activity in precancerous hepatic nodules

  1998cited by this paper
• Molecular mechanisms of hepatitis B and C viruses related to liver carcinogenesis.

  1998cited by this paper
• Incidence and risk factors for hepatocellular carcinoma in 967 patients with cirrhosis

  1998cited by this paper
• Clonal analysis of macronodules in cirrhosis

  1998cited by this paper
• Correlation between DNA methylation and pathological changes in human hepatocellular carcinoma.

  1998cited by this paper
• Cloning and expression of a developmentally regulated transcript MXR7 in hepatocellular carcinoma: biological significance and temporospatial distribution.

  1997cited by this paper
• Interspecies comparison of liver carcinogenesis: implications for cancer risk assessment.

  1997cited by this paper
• Chronic hepatitis C virus infection in humans: induction of hepatic nitric oxide synthase and proposed mechanisms for carcinogenesis.

  1997cited by this paper
• Laser Capture Microdissection

  1996cited by this paper
• Hepatocellular carcinomas with a high proliferation index and a low degree of apoptosis and necrosis are associated with a shortened survival.

  1996cited by this paper
• Codon 249 mutation of the p53 gene is a rare event in hepatocellular carcinomas from ethnic Chinese in Singapore.

  1995cited by this paper
• Incidence of hepatocellular carcinoma in chronic hepatitis B and C: A prospective study of 251 patients

  1995cited by this paper
• Clinical outcomes after transfusion-associated hepatitis C.

  1995cited by this paper
• Risk of hepatocellular carcinoma in patients with cirrhosis in Japan. Analysis of infectious hepatitis viruses

  1994cited by this paper
• DNA hypomethylation of proliferating cell nuclear antigen gene in human hepatocellular carcinoma is not due to cell proliferation.

  1993cited by this paper
• A multivariate analysis of risk factors for hepatocellular carcinogenesis: A prospective observation of 795 patients with viral and alcoholic cirrhosis

  1993cited by this paper
• Analysis of proliferating hepatocytes using a monoclonal antibody against proliferating cell nuclear antigen/cyclin in embedded tissues from various liver diseases fixed in formaldehyde.

  1992cited by this paper
• Oral contraceptive‐associated liver cell adenoma and hepatocellular carcinoma. Cytomorphology and mechanism of malignant transformation

  1991cited by this paper
• Prospective study of early detection of hepatocellular carcinoma in patients with cirrhosis

  1990cited by this paper

• Association of p53 Pro72Arg Polymorphism with Hepatocellular Carcinoma Risk in Hepatitis B Across Multiethnic Populations

  2026cites this paper
• Inducible gankyrin overexpression drives hepatocarcinogenesis in a liver-specific zebrafish model.

  2025cites this paper
• Acquisition Process and Clinical Relevance of dMMR‐Associated Mutational Signatures in Hepatocellular Carcinoma

  2025cites this paper
• Nicotinamide N-Methyltransferase (NNMT) and Liver Cancer: From Metabolic Networks to Therapeutic Targets

  2025cites this paper
• Advances in Immunotherapy in Hepatocellular Carcinoma

  2025cites this paper
• Artificial Intelligence in the Evolution of Interventional Therapy for Liver Cancer: Navigating the Tumor Microenvironment.

  2025cites this paper
• CYP2E1 overexpression in hepatocellular carcinoma modulates tumor invasion and migration via Wnt/β-catenin signaling pathway

  2025cites this paper
• Low-level shRNA Cytotoxicity Can Contribute to MYC-induced Hepatocellular Carcinoma in Adult Mice.

  2025cites this paper
• The epigenetic basis of hepatocellular carcinoma – mechanisms and potential directions for biomarkers and therapeutics

  2025cites this paper
• Unravelling the impact of the chromobox proteins in human cancers

  2025cites this paper
• Hub gene identification and immune infiltration analysis in hepatocellular carcinoma: Computational approach

  2024cites this paper
• CALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C Infection in Patients with Advanced Hepatocellular Carcinoma

  2024cites this paper
• Vanillin-Isatin Hybrid-Induced MARK4 Inhibition As a Promising Therapeutic Strategy against Hepatocellular Carcinoma

  2024cites this paper
• Effect of DNMT3A R882H Hot Spot Mutations on DDX43 Promoter Methylation in Acute Myeloid Leukemia

  2024cites this paper
• Circulating microRNAs as potential biomarkers of physical activity in geriatric patients with HCV

  2024cites this paper
• Understanding the Role of Connexins in Hepatocellular Carcinoma: Molecular and Prognostic Implications

  2024cites this paper
• Phenotypes of MASLD-associated hepatocellular carcinoma.

  2024cites this paper
• Discovery of novel and highly potent dual-targeting PKMYT1/HDAC2 inhibitors for hepatocellular carcinoma through structure-based virtual screening and biological evaluation

  2024cites this paper
• A comprehensive overview on the crosstalk between microRNAs and viral pathogenesis and infection

  2024cites this paper
• Expression of ALG8 in hepatocellular carcinoma and its diagnostic and prognostic significance

  2024cites this paper
• Pirfenidone Reverts Global DNA Hypomethylation, Promoting DNMT1/UHRF/PCNA Coupling Complex in Experimental Hepatocarcinoma

  2024cites this paper
• Role of immunotherapies and stem cell therapy in the management of liver cancer: A comprehensive review.

  2024cites this paper
• A hepatocellular carcinoma model with and without parenchymal liver damage that integrates technical and pathophysiological advantages for therapy testing.

  2024cites this paper
• Hepatocellular carcinoma in a transplanted donor liver and colon cancer developing in a patient with a complex background: A case report

  2024cites this paper
• BLVRA exerts its biological effects to induce malignant properties of hepatocellular carcinoma cells via Wnt/β-catenin pathway

  2024cites this paper
• Immunotherapy and liver cancer research trends and the 100 most cited articles: A bibliometric analysis

  2024cites this paper
• USP8 positively regulates hepatocellular carcinoma tumorigenesis and confers ferroptosis resistance through β-catenin stabilization

  2023cites this paper
• The Effect of Cynara cornigera L. in HepG2 Hepatocellular Carcinoma Cells

  2023cites this paper
• Five Critical Gene-Based Biomarkers With Optimal Performance for Hepatocellular Carcinoma

  2023cites this paper
• Precise construction of Regorafenib-loaded gold nanoparticles: investigation of antiproliferative activity and apoptosis induction in liver cancer cells

  2023cites this paper
• Histone Deacetylase Inhibition and Autophagy Modulation Induces a Synergistic Antiproliferative Effect and Cell Death in Cholangiocarcinoma Cells

  2023cites this paper
• Sex difference in the associations among liver function parameters with incident diabetes mellitus in a large Taiwanese population follow-up study

  2023cites this paper
• Long non-coding RNAs in hepatocellular carcinoma.

  2023cites this paper
• UCHL3 inhibits ferroptosis by stabilizing β-catenin and maintains stem-like properties of hepatocellular carcinoma cells.

  2023cites this paper
• Combinatorial impact of Chelerythrine and DADS in the restoration of liver physiology during carcinogenic exposure in mice (Mus musculus)

  2023cites this paper
• Potential role of human umbilical cord stem cells-derived exosomes as novel molecular inhibitors of hepatocellular carcinoma growth

  2023cites this paper
• Impact of Nanotechnology on Differentiation and Augmentation of Stem Cells for Liver Therapy.

  2023cites this paper
• AFP deletion leads to anti-tumorigenic but pro-metastatic roles in liver cancers with concomitant CTNNB1 mutations.

  2023cites this paper
• Prioritization of potential pharmacological targets for the development of anti-hepatocarcinoma drugs modulating the extrinsic apoptosis pathway: the reconstruction and analysis of associative gene networks help

  2023cites this paper
• Synthesis and Characterization of Supermagnetic Nanocomposites Coated with Pluronic F127 as a Contrast Agent for Biomedical Applications

  2023cites this paper
• Gene Expression Profiling Unravels Hepatitis C Virus (HCV) Infection-induced Temporal Alteration of Gene Expression in Hepatocellular Carcinoma (HCC)

  2023cites this paper
• Bio-diagnostic performances of microRNAs set related to DNA damage response pathway among hepatitis C virus-associated hepatocellular carcinoma patients

  2023cites this paper
• Establishment of Prognostic Signatures of N6-Methyladenosine-Related lncRNAs and Their Potential Functions in Hepatocellular Carcinoma Patients

  2022cites this paper
• RBM47 inhibits hepatocellular carcinoma progression by targeting UPF1 as a DNA/RNA regulator

  2022cites this paper
• Methylation site APC112043544 as a potential biomarker for post-transplant hepatocellular carcinoma recurrence.

  2022cites this paper
• Nicotinamide N-methyltransferase and liver diseases

  2022cites this paper
• Etodolac Fortified Sodium Deoxycholate Stabilized Zein Nanoplatforms for Augmented Repositioning Profile in Human Hepatocellular Carcinoma: Assessment of Bioaccessibility, Anti-Proliferation, Pro-Apoptosis and Oxidant Potentials in HepG2 Cells

  2022cites this paper
• Deciphering the Underlying Mechanisms of Formula Le-Cao-Shi Against Liver Injuries by Integrating Network Pharmacology, Metabonomics, and Experimental Validation

  2022cites this paper
• Consensus subtypes of hepatocellular carcinoma associated with clinical outcomes and genomic phenotypes

  2022cites this paper
• RNA sequencing analysis of hepatocellular carcinoma identified oxidative phosphorylation as a major pathologic feature

  2022cites this paper
• Analysis of Related Risk Factors of Microvascular Invasion in Hepatocellular Carcinoma

  2022cites this paper
• Evaluation of in vitro anticancer potential of pharmacological ethanolic plant extracts Acacia modesta and Opuntia monocantha against liver cancer cells.

  2022cites this paper
• β-Catenin signaling in hepatocellular carcinoma

  2022cites this paper
• Converged DNA Damage Response Renders Human Hepatocellular Carcinoma Sensitive to CDK7 Inhibition

  2022cites this paper
• Molecular mechanisms of Wnt/β-catenin activation in HCC

  2022cites this paper
• An automated and mobile magnetoresistive biosensor system for early hepatocellular carcinoma diagnosis.

  2022cites this paper
• Identification and Validation of Hub Genes with Poor Prognosis in Hepatocellular Carcinoma by Integrated Bioinformatical Analysis

  2022influential citation
• Hepatocellular carcinoma - prognostic criteria of individualized treatment.

  2022cites this paper
• Mitochondrial Dysfunction and Induction of Apoptosis in Hepatocellular Carcinoma and Cholangiocarcinoma Cell Lines by Thymoquinone

  2022cites this paper
• Nanotheranostics: A powerful next-generation solution to tackle hepatocellular carcinoma

  2022cites this paper
• Tumor microenvironment in heptocellular carcinoma

  2022cites this paper
• Custom gene expression panel for evaluation of potential molecular markers in hepatocellular carcinoma

  2022cites this paper
• Etiology, Pathogenesis, Diagnosis, and Practical Implications of Hepatocellular Neoplasms

  2022cites this paper
• RBM47 inhibits hepatocellular carcinoma progression by targeting UPF1 as a DNA/RNA regulator

  2022cites this paper
• Biomarkers and Genetic Markers of Hepatocellular Carcinoma and Cholangiocarcinoma—What Do We Already Know

  2022cites this paper
• Construction of functionalized ruthenium-modified selenium coated with pH-responsive silk fibroin nanomaterials enhanced anticancer efficacy in hepatocellular cancer

  2022cites this paper
• Parafibromin Is Highly Expressed in Hepatocellular Carcinoma and Its Expression Correlates with Poor Prognosis

  2022cites this paper
• Mutational signatures representative transcriptomic perturbations in hepatocellular carcinoma

  2022cites this paper
• Effect of cirrhosis and hepatitis on the prognosis of liver cancer

  2022cites this paper
• Integrating Clinical and Genomic Factors to Predict Hepatocellular Carcinoma Recurrence Following Radical Liver Resection

  2022cites this paper
• Exon Array Analysis to Identify Diethyl-nitrosamine Differentially Regulated and Alternately Spliced Genes in Early Liver Carcinogenesis in the Transgenic Mouse ATT-myc Model

  2021cites this paper
• TERT Mutations Correlated With the Prognosis of Patients With Hepatitis B-Related Hepatocellular Carcinoma Underwent Curative Hepatectomy

  2021cites this paper
• p53 and rb promoter methylation in hepatitis C virus-related chronic hepatitis and hepatocellular carcinoma

  2021cites this paper
• SMALF: miRNA-disease associations prediction based on stacked autoencoder and XGBoost

  2021cites this paper
• Risk Assessment of Hepatitis C Virus Resistance to Ns3/4a Protease Inhibitors (Pis)

  2021cites this paper
• Earliest hepatitis B virus-hepatocyte genome integration: sites, mechanism, and significance in carcinogenesis

  2021cites this paper
• Targeting CALM2 Inhibits Hepatocellular Carcinoma Growth and Metastasis by Suppressing E2F5-mediated Cell Cycle Progression

  2021cites this paper
• Silencing CDCA8 Suppresses Hepatocellular Carcinoma Growth and Stemness via Restoration of ATF3 Tumor Suppressor and Inactivation of AKT/β–Catenin Signaling

  2021cites this paper
• Signaling pathways in hepatocellular carcinoma.

  2021cites this paper
• Clinical and Molecular-Based Approach in the Evaluation of Hepatocellular Carcinoma Recurrence after Radical Liver Resection

  2021cites this paper
• Construction and validation of an N6-methyladenosine-associated prognostic signature in hepatocellular carcinoma

  2021cites this paper
• The Evolving Role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Treatment

  2021cites this paper
• AICAR and Compound C negatively modulate HCC-induced primary human hepatic stellate cell activation in vitro.

  2021cites this paper
• Piezo1 impairs hepatocellular tumor growth via deregulation of the MAPK-mediated YAP signaling pathway.

  2021cites this paper
• HuR Protein in Hepatocellular Carcinoma: Implications in Development, Prognosis and Treatment

  2021cites this paper
• Synergistic Effect of Barbadensis miller and Marsdenia Condurango Extracts Induces Apoptosis Promotes Oxidative Stress by Limiting Proliferation of Cervical Cancer and Liver Cancer Cells

  2021cites this paper
• Hepatocellular Carcinoma Pathology

  2021cites this paper
• The Combined Diagnostic Accuracy of Serum Alpha Fetoprotein and Des-Gamma Carboxyprothrombin in Hepatocellular Carcinoma among Chronic Liver Disease Patients in Ilorin

  2021influential citation
• Gastrointestinal tumors and infectious agents: A wide field to explore

  2021cites this paper
• Paraneoplastic syndrome frequency and prognostic effect in hepatocellular carcinoma patients

  2021cites this paper
• MDM2 (T309G) Gene Polymorphism Determines the Susceptibility of Hepatocellular Carcinoma in Bangladesh

  2021cites this paper
• Mutations in TP53 and PIK3CA genes in hepatocellular carcinoma patients are associated with chronic Schistosomiasis

  2021cites this paper
• Therapeutic targeting of alternative splicing to inhibit hepatocellular carcinoma metastasis

  2021cites this paper
• SOCS3-mediated activation of p53-p21-NRF2 axis and cellular adaptation to oxidative stress in SOCS1-deficient hepatocellular carcinoma

  2021cites this paper
• Epigenetic mechanisms of hepatocellular carcinoma progression: Potential therapeutic opportunities

  2021cites this paper
• Impact of aging on primary liver cancer: epidemiology, pathogenesis and therapeutics

  2021cites this paper
• Development of Coriandrum sativum Oil Nanoemulgel and Evaluation of Its Antimicrobial and Anticancer Activity

  2021cites this paper
• Changing Etiology and Epidemiology of Human Liver Cancer

  2021cites this paper
• Human Serum Albumin Nanoparticles as a Carrier for On-Demand Sorafenib Delivery.

  2021cites this paper
• NAFLD-Related Hepatocarcinoma: The Malignant Side of Metabolic Syndrome

  2021cites this paper